Treatment Registry
TR-0216 ActiveRecorded September 2, 2026

Unspecified GLP-1

Sold by T2D.com · every unspecified glp-1 record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$170

Medication · Use Our Prescribers - Monthly, All-Inclusive$170

Added from the figures recorded below.

Price

TermPer monthCharged today
Use Our Prescribers - Monthly, All-Inclusive

Includes Prescriber & Continued Patient Support Fast Onboarding No Contracts, Cancel Anytime $170/month All-Inclusive

source

Per month$170Charged today$170
Visit T2D.com

We earn nothing from this link. T2D.com has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberBoth
Cancellation“You can cancel a Subscription by visiting your "Account" on the Services. You will be responsible for all Subscription Fees incurred for the then-current Subscription period.”

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from t2d.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026T2D.com never names the drug for its main 'Use Our Prescribers' plan on the pricing block (elsewhere the site says it offers compounded Semaglutide and Tirzepatide generally), so that $170/mo entry is recorded as unspecified GLP-1. Form (vial vs pen) is never stated. About-us and contact-us paths 404'd; /pricing, /faq and /plans also 404'd -- pricing lives at /weight-loss instead.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0216
Readings
1

Related records

What else T2D.com sells

All T2D.com programs and terms

Unspecified GLP-1 at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 72 records of the same molecule.

Cite this entry

Treatment Registry. (2026). T2D.com unspecified GLP-1 (TR-0216). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0216

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.